Owen McManus

Owen McManus

Company: Q-State Biosciences

Job title: Chief Technology Officer


Therapeutic Discovery Platform for Oligonucleotides Targeting Neurodegeneration & other CNS Disorders 11:30 am

Building a high throughput platform for functional characterization of neuronal activity in the context of genetically defined CNS diseases Q-State uses this platform to inform design and development of antisense oligonucleotides targeting underlying disease mechanisms Presenting examples from projects targeting Spinocerebellar Ataxia 13, Spastic Paraplegia Type 49 and KCNT1-related Developmental and Epileptic EncephalopathyRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.